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There is growing evidence that the metabolic network is an integral regulator of cellu-
lar physiology. Dynamic changes in metabolite concentrations, metabolic ﬂux, or network
topology act as reporters of biological or environmental signals, and are required for the
cell to trigger an appropriate biological reaction. Changes in the metabolic network are
recognized by speciﬁc sensory macromolecules and translated into a transcriptional or
translational response. The protein family of sirtuins, discovered more than 30years ago
as regulators of silent chromatin, seems to fulﬁll the role of a metabolic sensor during
aging and conditions of caloric restriction. The archetypal sirtuin, yeast silent information
regulator2 (SIR2), is an NAD+ dependent protein deacetylase that interacts with metabolic
enzymes glyceraldehyde-3-phosphate dehydrogenase and alcohol dehydrogenase, as well
as enzymes involved in NAD(H) synthesis, that provide or deprive NAD+ in its close prox-
imity. This inﬂuences sirtuin activity, and facilitates a dynamic response of the metabolic
networktochangesinmetabolismwitheffectsonphysiologyandaging.Themolecularnet-
work downstream Sir2, however, is complex. In just two orders, Sir2’s metabolism related
interactions span half of the yeast proteome, and are connected with virtually every physi-
ological process.Thus, although it is fundamental to analyze single molecular mechanisms,
it is at the same time crucial to consider this genome-scale complexity when correlating
single molecular events with complex phenotypes such as aging, cell growth, or stress
resistance.
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ROBUSTNESS AND SENSING OF THE METABOLIC NETWORK
Metabolite concentrations are driving forces for enzymatic reac-
tions (Bruice, 2002), which implies that there is evolutionary
pressure to keep them in a narrow, controlled range. Indeed,
intracellular metabolite concentrations are extraordinarily robust
againstexternalaswellasgeneticperturbations(Blanketal.,2005;
Ishii et al., 2007). Important for this robustness is a modular
structure of the metabolic network. Modularity of substructures
grants network stability, as perturbations may affect the module
but not necessarily the ﬂux of the entire system (Parter et al.,
2007; Kreimer et al., 2008). Indeed, system-wide consequences
on metabolite concentration levels are virtually limited to pertur-
bations that affect common, network-interconnecting metabolic
co-factors (i.e., ATP, SAM, or NADH; Blank et al., 2005; Kuepfer
et al.,2005).
Maintaining metabolite concentrations requires molecular
sensing and monitoring of the network, which occurs both at the
level of (a) concentration and (b) metabolic ﬂux (Grüning et al.,
2010; Heinemann and Sauer, 2010). An illustrative example for
network regulation at the concentration level is purine biosynthe-
sis. Two intermediates, 5 -phosphoribosyl-5-amino-4-imidazole
carboxamide (AICAR) and succinyl-AICAR (S-AICAR), bind to
the transcription factors Pho2, Pho4, and Bas1. An increase in
their concentration induces dimerization of these transcription
factors and triggers expression of genes involved in their own
biosynthesis (Pinson et al., 2009). This feed-forward mechanism
may be required to react appropriately to energy shortage; it may
allow the cell to decipher if rapid proliferation or starvation is the
reason for the energy shortage.
AICAR and S-AICAR represent so called reporter metabo-
lites, metabolites whose concentration controls a transcriptional
response, or in the original deﬁnition, metabolic intermediates
that are surrounded by transcriptional changes (Patil and Nielsen,
2005;Cakir et al.,2006) The TOR pathway also contains an exam-
ple of the second considerably less understood type of metabolite
control, that of ﬂux-based monitoring of the metabolic network.
In mammalian cells the mTOR interactor Rheb is bound to
theglycolyticenzymeglyceraldehyde-3-phosphatedehydrogenase
(GAPDH). Under low glucose conditions,GAPDH prevents Rheb
from binding to mTOR and thereby inhibits mTORC1 signaling.
High glycolytic ﬂux suppresses the interaction between GAPDH
and Rheb and thus allows Rheb to activate TOR signaling (Lee
et al.,2009).
THE METABOLIC NETWORK AND THE AGING PROCESS
Thesesystemsofmetabolomeregulationplayimportantrolesdur-
ing the aging process. Metabolism is regarded as a cause of aging,
as it is responsible for the increase in molecular and cellular dam-
ageobservedinsenescentcells.Althoughitisclearthatthedamage
on macromolecules contributes to cell death and apoptosis and is
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age dependent, it is subject to ongoing debate if this damage is
indeed the basis, or rather a consequence of the aging process, or
both (Muller et al., 2007; Blagosklonny, 2008; Gruber et al., 2008;
Blagosklonny and Hall, 2009).
Yeast aging research distinguishes between replicative and
chronological aging. The ﬁrst measure, also called mother cell-
speciﬁcaging,describeshowmanycellcyclesayeastcellcompletes
before senescence, or in other words, how many daughters bud
from each mother (Mortimer and Johnston, 1959). The second,
termed “chronological aging,” deﬁnes how long a yeast culture
enduresat30˚Cinanon-dividingstate(FabrizioandLongo,2003),
orinitsspecialcaseof“hibernatinglifespan,”at4˚C(Postmaetal.,
2009). Although it is in general assumed that replicative aging
shares more features with the aging process in humans (Laun
et al., 2006), both measures depend on the metabolic network.
The accumulation of oxidatively damaged proteins during both
chronological and replicative aging is undisputed, however, at the
sametimethereexistseveralyeastmutantswhicharestronglyoxi-
dantresistant,butshowmassivelyshortenedlifespans[suchasper-
oxiredoxin tsa1-B7; Timmermann et al.,2010,or triosephosphate
isomerase (tpi1) mutants; Ralser et al., 2007). This indicated that
the intense relationship between oxidative damage and aging is
rathercomplex,asitisthefunctionof sirtuins,asdiscussedbelow.
Among oxidizing molecules that originate in biosynthetic
mechanisms, research predominantly focused on reactive oxygen
species (ROS). A major source of ROS in the cell is superoxide
(O2
·−),whichleaksfromcomplexIIIandcomplexI(inyeastonly
complexIII,asitlackscomplexI)of themitochondrialrespiratory
chain(CadenasandDavies,2000;Breitenbachetal.,2012).Infact,
superoxide production is quantitatively quite signiﬁcant,as 1–2%
of consumed oxygen is interconverted into this agent (Cadenas
and Davies, 2000). However, there are other important sources of
ROS, such as the mitochondrial external NADH dehydrogenases
Nde1,Nde2andthemitochondrialinternalNADHdehydrogenase
Ndi1, which feed the respiratory chain without proton pumping
(Luttik et al., 1998; Li et al., 2006), or the degradation of fatty
acids (Martin et al.,2007). Moreover,other oxidizing agents,such
as reactive nitrogen species (RNS) also contribute signiﬁcantly to
macromolecular damage (Novo and Parola,2008).Although RNS
arelesswellstudiedinyeastthaninplantsormammals,theyseem
toplayaroleintheyeastagingprocess,atleastitwasreportedthat
they accumulate in senescent RAS mutants (Wilhelm et al.,2006).
Production of these oxidizing agents is a natural, inevitable
consequence of metabolic activity. In young and healthy cells,
natural ROS production is unproblematic as all living cells are
evolutionarily adapted and are able to clear this ROS through a
series of enzymatic and non-enzymatic antioxidant systems (Sies,
1997; Cadenas and Davies, 2000). These stabilize ROS levels; for
instance, respiring and non-respiring yeast cells possess the same
levelsof superoxideandhydrogenperoxide(Gruningetal.,2011).
Theinquantitativetermsmostimportant(butnottheonly)redox
buffer is the glutathione system (Meister and Anderson, 1983;
Grant et al., 1996). Glutathione, a cysteine containing tri-peptide
of non-ribosomal origin, clears ROS by being oxidized. The oxi-
dized form is then recycled by glutathione reductase, an enzyme
which restores GSH under NADPH consumption (Massey and
Williams, 1965). Regulation of the NADPH supply is critical for
this process. This metabolite is consumed in large amounts under
oxidative stress conditions,but cannot be provided in large excess,
as this would shift the redox balance toward reduction (“reductive
stress”),which is another pathogenic situation (Rajasekaran et al.,
2007; Brandes et al.,2009).
The dynamic increase in NADP+ reduction during oxida-
tive stress has largely been attributed to increased activity of the
pentose phosphate pathway (PPP),a catabolic carbohydrate path-
way alternative to glycolysis (Wamelink et al., 2008). Although
other cellular reactions are capable of maintaining a normal
NADPH/NADP+ ratio under anaerobic growth conditions, they
fail to do so upon contact with an oxidant or when they respire
at high rates. A H2O2 treatment of zwf1Δ yeast – lacking the
ﬁrst NADP+ reducing enzyme of the PPP (glucose 6 phos-
phate dehydrogenase Zwf1) – causes an immediate collapse of
the NADPH/NADP+ ratio resulting in massive cellular sensitivity
to oxidants (Castegna et al.,2011).
REGULATION OF DYNAMIC PPP ACTIVATION
The dynamic activation of the PPP is a vivid example for the
adaptation of the metabolic network to changing environmen-
tal conditions. Upon the addition of an oxidant, PPP activity is
increased in temporally discrete steps. This regulation involves
both the transcriptome and metabolome level, beginning with
the latter (Larochelle et al., 2006; Chechik et al., 2008; Ralser
et al.,2009a). In addition,glycolysis and the PPP are self-adapting
to prevent oxidative stress when cells switch from anaerobic to
oxidativemetabolism.Lowactivityof yeastpyruvatekinase[PYK;
an enzyme which catalyzes the last glycolytic step converting
phosphoenol-pyruvate(PEP)topyruvate]inrespiringcellscauses
accumulation of its substrate PEP. PEP in turn acts as feedback
inhibitoroftriosephosphateisomerase(Tpi1).Theresultantblock
in glycolysis drives ﬂux into the PPP (Gruning et al., 2011). This
mechanism helps to balance the increased ROS production dur-
ing oxidative metabolism, and keeps the ROS level similar to that
of non-respiring cells. However,interruption of this feedback cir-
cuit makes cells vulnerable to oxidative stress: when respiration is
inducedinzwf1Δyeast,ROSaccumulate,anddamagemacromol-
eculesandorganellesbyoxidation(Gruningetal.,2011).Recently,
it has become clear that this mechanism is conserved in mam-
malian cells, and might explain central features of the Warburg
effect, which is a decrease in oxidative respiration during cancer
formation(Warburg,1956).Alsocancercellssufferfromoxidative
damage,andredirectthemetabolicﬂuxviaPYK forinducingROS
clearance (Anastasiou et al.,2011; Grüning and Ralser, 2011).
THE DISCOVERY OF YEAST SIRTUINS
The metabolic shift from glycolysis to the PPP is one of the best
studied examples, where a metabolic re-conﬁguration induces
adaptationof thetranscriptome,andtheglycolysis/PPPtransition
functionsasa“metabolicsignalingcascade”inducedunderoxida-
tive stress (Kruger et al.,2011). The response in the transcriptome
points to the existence of regulating macromolecules that detect
these changes in metabolic activity and translate this information
into a transcriptional response. Sirtuins are such proteins, they
react to changes in metabolic activity and are closely connected
with metabolites and enzymes of glycolysis.
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The papers dealing with the sirtuin protein family recently
exceeded2200.TheauthorswhoﬁrstdiscoveredtheSaccharomyces
cerevisiae SIR2 gene,from which the name,sirtuin is derived,cer-
tainly could not have dreamed that their discovery would within
just a few decades lead to such an enormous “gene rush” in
the scientiﬁc community around the world. For the most part,
this development is caused by the association of sirtuins in the
aging process. However,the exact nature of this connection is still
unclear, and the debate about whether or not the sirtuins are part
of a public mechanism of aging (term meaning cross-species aging
mechanism; Martin et al., 1996) is still ongoing. Prominently, the
involvement of sirtuins in caloric restriction (also called “calo-
rie restriction” or “dietary restriction”) intervention in the aging
processiscentraltothisdebate,asitisthemechanismof actionof
resveratrol, a plant stilbene which was believed to extend S. cere-
visiae replicative lifespan though activating Sir2 (Lin et al., 2000;
not further discussed in this review).
The SIR (silent information regulator) mutants and genes were
discovered by Rine et al. (1979). Four different complementa-
tion groups of unlinked recessive yeast mutations were found
that all led to the same phenotype: the mutants were extragenic
suppressors of the matα1-5 mutation. The suppressor mutation
caused cells to regain functional MATα genetic information and
to mate again normally. This effect was completely dependent on
the presence of MATα genetic information at the distant HML
locus near the left telomere of chromosome III. Viewed from
2012, it is not surprising that the sir mutations were shown to
inﬂuence not only mating, but also sporulation efﬁciency. Her-
skowitz and many others have established that mating of alpha
strains needs the functional gene product Matα1 and sporulation
requires the functional gene products Mata1 and Matα2. In most
laboratory strains, the HML locus near the left telomere of chro-
mosome III contains functional but silent copies of the alpha1
and alpha2 genes, while the HMR locus located near the right
telomer of chromosome III, contains functional but silent copies
of thea1anda2 genes.Theﬁrstidentiﬁedmutantsir allele(sir1-1)
suppressed all known mating deﬁcient and sporulation-deﬁcient
mutations located in the mating type locus. All four SIR genes
are needed independently for transcriptional repression of HML
and HMR. Importantly, it was later shown (Moazed et al., 1997;
Liouetal.,2005)thatthreeof thefourSirproteins(Sir2/Sir3/Sir4)
form a tight heteromeric complex in vitro; Sir1 is not part of
this complex. (Please see Huang, 2002;f o raR e v i e wo fp r o t e i n s
that are needed for silencing and for the pleiotropic functions of
Sir2).
We know that the sir mutations relieve the transcriptional
repression of genetic information at HML and HMR, and from
work in the ensuing decades that the Sir gene products bind to
controlling segments in the DNA of HML and HMR,and are part
of the chromatin at those loci. In addition, the Sir proteins are
found at telomeres of all chromosomes and at the rDNA locus
on chromosome XII (Strahl-Bolsinger et al., 1997; Mekhail and
Moazed, 2010). The mutations were found at the time to have
no other phenotypes apart form silent mating type information
expression. Herskowitz and Oshima (1981) wrote that “it is clear
that sir mutants are not grossly pleiotropic.”This statement is no
longer true,as will be discussed below.
It was shown that Sir proteins interact genetically with histone
H4,indicatingthattranscriptionalsilencingincludesH4modiﬁca-
tion and that co-operation of H4 with Sir2 is needed for silencing
(Imaietal.,2000).TheﬁrsthintofaspecialroleforSir2thatdiffers
from the other three Sir proteins came from the work of Easton-
Esposito and her colleagues (Gottlieb and Esposito, 1989; Fritze
et al., 1997). They showed that Sir2 (but not Sir 1, Sir3, or Sir4)
suppresses non-allelic recombination between the tandem copies
of rDNA on chromosome XII. The authors concluded that Sir2
is a limiting component required for chromatin modeling at the
rDNA locus. This was a very important step toward our present
understanding of Sir2. Guarente (1999) reviewed the role of the
Sirproteinsinsilencing,chromatinorganizationattelomers,silent
matingtypeloci,theNOR(nucleolarorganizer),inrepairof dou-
blestrandbreaks,recombination,cellcycleregulation,andmother
cell-speciﬁc aging.
THE DISCOVERY OF Sir2’S ROLE IN AGING AND THE METABOLIC
NETWORK
Among other groups, the lab of Guarente (1999) started work on
yeast mother cell-speciﬁc aging in the 1990s. While it is to the
present day, for technical reasons, not possible to directly select
for replicatively long-lived yeast mutants, several indirect proto-
cols for mutation isolation have been used. After conventional
chemical mutagenesis of haploid yeast cells and applying starva-
tion stress, replicatively long-lived mutants were isolated among
the survivors of extended periods of starvation (Kennedy et al.,
1995). One of them was located within SIR4 and was shown to
be a “semi-dominant” missense mutation. This led to the possi-
bility that the Sir complex could have a special role in replicative
aging. Consequently, all components of this complex were tested
for aging phenotypes (Kaeberlein et al., 1999). It was shown that
yeast replicative lifespan depended on the presence of SIR2, SIR3,
andSIR4,butnotonSIR1.Again,SIR2 wasshowntohaveaspecial
role that is slightly different from that of SIR3 and SIR4. Compar-
ing the deletion mutants of the three genes (sir2Δ, sir3Δ, and
sir4Δ) it appears that sir2Δ had the largest effect (−50%). Con-
versely, overexpression constructs increased lifespan, again with
Sir2 overexpression having the largest effect. It appeared that the
effects of sir3Δ and sir4Δ could be fully compensated by delet-
ing HMLα in the used haploid MATa strain,while the same effect
was not seen in sir2Δ yeast (Kaeberlein et al., 1999). The authors
explained these results with Sir2-triggered repression of minicir-
cles (ERCs), formed by non-allelic recombination of the tandem
repeated copies of rDNA in the NOR on chromosome XII. These
minicirclesbehavelikenon-centromericplasmids,thereforeaccu-
mulate in mother cells but are very inefﬁciently transmitted to
daughter cells. In the mother cells, they can become so abundant
with replicative age that either the sheer mass of the circular DNA
m a yh a v ea na d v e r s ee f f e c to nt h ec e l l s( Sinclair and Guarente,
1997) or they may titrate away the Sir2 which is then limiting for
the other important functions like silencing of HML and HMR.
This most likely contributes to the observed mating defect of old
haploid mother cells. Other functions compromised in these cells
are binding and silencing to telomeres and adjacent chromosomal
regions,affectingamongotherthingsunwantednon-homologous
end-joining (NHEJ),perhaps leading to replication problems and
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genome instability in the old mother cells (Gottschling, 2000;
McMurray and Gottschling, 2004). FOrk Blocking less 1 (Fob1)
is a non-essential recombination factor needed for keeping the
sequences of the rDNA repeat units constant. Preventing the for-
mation of minicircles by deleting fob1, increases the replicative
lifespan of yeast by about 6 generations (Defossez et al., 1999).
However, the SIR mutations (in particular sir2Δ)h a v ee f f e c t so n
lifespanevenintheabsenceof minicircles,andthegaininlifespan
in fob1Δ strains is relatively small (Defossez et al., 1998; Borgh-
outs et al.,2004; Heeren et al.,2009). This underlines the fact that
replicative aging of yeast and aging in general is a very multicausal
process and depends not only on the genetic makeup of the cell
but also on many external conditions. Thus,there is no single and
“most important”mechanism of aging.
Minicircles have been described only in the yeast S. cerevisiae
and its close relatives, but not in the other eukaryotic model sys-
tems of aging, Drosophila melanogaster, Caenorhabditis elegans,
and Mus musculus. We therefore call minicircles a“private mech-
anism of aging”(the term meaning species-speciﬁc going back to
Martin,1997). However,in the non-yeast model systems of aging,
theSIR2 geneanditsproteinfamilydoesexistandisevensplitinto
a number of paralogs (i.e., seven in humans) some of which are
essential for life in mammals (McBurney et al., 2003; Chen et al.,
2005).
Despite the absence of minicircles, lifespan extending prop-
erties for Sir2 homologs have been reported for C. elegans and
D. melanogaster. However, recently, these studies received a seri-
ous setback as these lifespan phenotypes were lost by out-crossing
the Sir2 overexpression alleles (Burnett et al., 2011), or at least,
wereoverestimatedinoneoriginalreport(TissenbaumandGuar-
ente,2001) due to co-segregation of an unlinked second mutation
which alters lifespan as well (Viswanathan and Guarente, 2011).
We think that the question of sirtuins involvement in lifespan
extensioninnon-yeastspeciesisundecidedatpresent.Thecareful
genetic crosses of Burnett et al. above everything show one fact:
due to the extreme (and not fully analyzed) pleiotropy and the
largenumberof targetgenesof thedeacetylaseSir2,itisextremely
important to investigate co-segregation of the aging phenotype
with the overexpression mutation to determine hidden factors in
the genetic background.
The situation is also different for the involvement of Sir2 in
the second measure of yeast aging, chronological lifespan. This
measure is quite different to replicative aging as it describes the
survival of a stationary yeast population rather then the survival
of an individual cell. Indeed, gene sets which extend replicative,
chronological, and also hibernating lifespan are only marginally
overlapping (Laun et al., 2006; Postma et al., 2009). Nonetheless,
systematic analysis of chronological aging led to the discovery of
aging factors conserved from yeast to mammals, including the
TOR pathway (Fabrizio and Longo, 2003; Powers et al., 2006).
Sir2 has however shortening effects on this measure: Lack of Sir2
along with calorie restriction and/or mutations in the yeast AKT
homolog, Sch9, or Ras pathways caused a dramatic chronological
lifespan extension (Fabrizio et al., 2005).
Irrespective of this debate, studies on Sir2’s involvement in the
aging process stimulated a massive amount of research on Sirtu-
ins and improved our understanding of their regulatory potential
in humans. In animal species SIRT1 shows the highest degree of
sequence similarity with yeast Sir2, and displayed aging-related
physiological effects in spite of the absence of ERCs (Tissenbaum
and Guarente, 2001; Rogina and Helfand, 2004; Chen et al., 2005;
Herranz and Serrano, 2010). These effects were explained by the
highnumberandgreatvarietyofproteintargetsofSir2deacetylase
activity (Westphal et al., 2007). In mammals, considering the tar-
getsthathavesofarbeendiscovered,theyconnectsirtuinsactivity
to metabolic regulation, stress resistance and diseases of old age
like diabetes and cancer.
ASYMMETRIC SEGREGATION, CALORIC RESTRICTION AND Sir2
The literature on Sir2 homologs and aging is closely interrelated
with(i)asymmetricsegregation,and(ii)caloricrestriction.These
seemtobeunrelatedprocessesfromthemechanisticpointof view,
but both protect cells from oxidative damage.
AsymmetricsegregationinyeastS.cerevisiae wasfoundinaged
mother cells that retain oxidatively damaged proteins; daughter
cells are formed from a fresh set of proteins. This is Sir2 depen-
dent; sir2Δ mothers are unable to protect their daughters from
the transmission of damaged proteins during cytokinesis (Aguila-
niu et al., 2003). Thus, sir2Δ daughters suffer much earlier from
molecular damage as do wild-type cells.
It is not yet clear if Sir2 homologs play a similar role in other
species. Thus, it cannot be excluded that Sir2’s modulation of
asymmetric segregation is again a yeast’s private mechanism of
aging. In contrast, however, the second treatment associated with
Sir2’s anti aging effects, caloric restriction, has been found to
increase lifespan and improve health in all tested species from
yeast to humans (Sohal andWeindruch,1996). Deleting or down-
regulating the respective Sir2 homologous gene in the aforemen-
tioned species abrogates effects of caloric restriction on lifespan
and on the preventive effect of caloric restriction on diseases of
aging, like diabetes (Chen et al., 2005; Lamming et al., 2005; Qiu
et al., 2010a). However, the question of whether the yeast SIR2
gene is needed for the increase the replicative lifespan by a reduc-
tion of glucose is an open one till the present day. One laboratory
maintainsthattheeffectof thismildCRiseffectiveindependently
of Sir2,andisintheabsenceof Sir2dependentonHst2,aSir2par-
alog (Lamming et al., 2004, 2005; Smith et al., 2007). The HST2
gene is a member of a small family of four yeast genes which is
highly homologous and functionally related to Sir2 (Derbyshire
et al., 1996). However, another laboratory insists that life span
extension by CR is strictly dependent on the presence of the SIR2
gene (Lin et al.,2000).
METABOLIC EFFECTS OF CALORIC RESTRICTION IN YEAST
ThislifespanextensioninregardtoSir2hasbeenstudiedbyreduc-
ing glucose concentration from the usual 2% to the lower 0.5% in
S. cerevisiae media (Lin et al., 2000). Although this treatment is
referred as caloric restriction, it is – if any – a mild form of it,
and it is worth speculating that 0.5% glucose may closer resem-
ble the nutrient availability in the yeast’s natural environment.
Interestingly, it was described that an induction of respiration is
required for the lifespan extending effects of a growth on 0.5%
glucose, and that Sir2 is involved in this process (Lin et al., 2002).
Importantly,S.cerevisiae isa“Crabtree”positiveyeast:highglucose
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concentrations (but not other carbon sources such as galactose,
rafﬁnose or glycerol) repress S. cerevisiae respiration. Analyzing
chronological lifespan, it was shown that in contrast to glucose,
inducing CR by reducing the content of galactose, rafﬁnose, or
glycerolplusethanoldidnotenhancelifespan.Moreover,thelifes-
pan extending effects of diminished glucose concentration were
not observed in the Crabtree negative yeast Kluyveromyces lactis
(Oliveira et al., 2008). In this context, it is worth to mention that
yeaststrainswithextendedhibernatinglifespan(mutantsthatsur-
vived 5years in the cold room) contain a high number of strains
which cannot survive without respiratory activity (Postma et al.,
2009). Moreover, when respiration was induced by PYK or by
shifting to galactose, yeast cells developed a strong increase in
resistance to different oxidants (Gruning et al., 2011), but in the
Crabtree negative K. lactis, limitation of glucose supply did not
protectagainstROSasitdoesinS.cerevisiae (Oliveiraetal.,2008).
Recently, also nitric oxide (NO) production was associated with
these lifespan extending effects of low glucose levels. A reduction
of glucoseconcentrationinducesS.cerevisiae NOproduction;and
NO donors such as GSNO (S-nitrosoglutathione) were sufﬁcient
to extend lifespan (Li et al., 2011). Thus, it is conceivable that the
lifespan extending effects of reducing glucose to 0.5% result from
circumventing glucose repression causing an activation of mito-
chondrial metabolism, respiration, and the cellular antioxidant
machinery.
Additionally, the nutrient-responsive signaling kinase TOR
(targetof rapamycin),andtheconcentrationsof NAD+ playarole
in this process. Although it was reported that tor1 mutants have
an increased lifespan independently from Sir2 activity (Kaeber-
lein et al., 2005), other results supported the notion that the TOR
mediated lifespan extension is a direct result of enhanced NAD+
salvagepathwayactivityandSir2targeting(Silvaetal.,2009).Itwas
shown that rapamycin and nitrogen starvation leads to enhanced
Sir2 association with rDNA via the inhibition of TOR complex
1 (TORC1; Ha and Huh, 2011). To undergo these reactions, Sir2
required the salvage pathway Nicotinamidase Pnc1 and Net1, the
core subunit of the RENT complex, indicating that TORC1 activ-
ity results in increased silencing of RNA polymerase genes at
rDNA loci, enhanced histone deacetylation and reduced homol-
ogous recombination at rDNA repeats. This allowed to conclude
on a lowered number of ERCs as basis for this lifespan exten-
sion (Ha and Huh, 2011). Indeed, NAD+ and nicotinamide are
directlyinvolvedinthefunctionalactivityof Sir2inrelationtothe
metabolic network.
THE ENZYMATIC FUNCTION OF Sir2 AND LINKS TO THE
METABOLIC NETWORK
Sir2 has deacetylase and ADP-ribosyl-transferase activity, both
of which are required for deacetylating proteins. Sir2 catalyzes a
NAD+-dependent ε-N-acetyl-lysine deacetylation from proteins
(including histones, class III HDACs), resulting in deacetylated
protein, nicotinamide, and the molecule 2 O-acetyl-ADP-ribose
(OAADPR; Moazed,2001; Jackson and Denu,2002). It is an open
ﬁeldof researchif Sir2canforthisreasonsensetheNAD+/NADH
ratio(Yu andAuwerx,2009;Yuetal.,2009). FirstSir2activitymay
be directly regulated by changes in the cellular redox potential.
Thisnotionisperhapsnaïve,asthemaindeterminantof theredox
potentialofthecellistheglutathioneredoxcoupleaccordingtothe
Nernst equation. The measured changes in NAD+/NADH ratio
during CR have only minor inﬂuence on this measure (Schafer
and Buettner, 2001). In this line, Anderson et al. (2003) showed
that reducing the glucose intake decreases nuclear NAD+ levels
in vivo, but that yeast Sir2 as well as its mammalian homolog
SirT1 are not affected by this alteration in NAD+/NADH ratios.
Theseassumptionshoweverrequireamoredifferentiatedelab-
oration as the overall redox state measure does not necessarily
reﬂect the cofactor presence in the protein’s microenvironment.
A signiﬁcant part of NAD+ is protein bound, as it is presumably
Sir2, and therefore protein complexes may feed Sir2 directly with
its cofactor. Recently, Sir2 was the basis for several genome-scale
screens to identify genetic and physical interactors. These include
a genome-wide screen to identify anti-silencer factors (Raisner
and Madhani, 2008), and proteomic analyses that use methods of
label-free protein quantiﬁcation (Rye et al., 2011). Together with
other genes identiﬁed in earlier targeted and untargeted screens,
theyformalargenetworkwhichisindicativeoftheglobalfunction
ofSir2.BasedontheinformationstoredintheBioGriddatabaseas
of December2011(Starketal.,2006),wegeneratedametabolism-
centric protein interaction network for Sir2 (Figure 1). This net-
work contains all direct genetic and physical interaction partners
of the enzyme, and interactors that are associated with the gene
ontology (GO) term“metabolism”or“carbohydrate metabolism”
are highlighted. These two GO terms have been assigned to 40
genes out of the total 84 annotated Sir2 interactors (Figure 1A).
To illustrate the large interconnectivity that comes with these 40
genes, the network was expanded with their direct interactors,
which yielded a “metabolism-centric” Sir2 interactions network
(Figure 1B). The inclusion of the second order Sir2 interactors
considerably increased the network and its interconnectivity; the
network is formed of 2888 vertices interconnected by 5566 edges.
Thus, in just two steps, the metabolic interaction network of Sir2
interconnects half of the yeast proteome.
Sir2 INTERACTING ENZYMES WHICH GENERATE NAD+ IN
CLOSE PROXIMITY MODULATE ITS BIOLOGICAL FUNCTION
In Table A1 in Appendix we list the genes of the direct (ﬁrst
order) interactors of Sir2, and their associated GO terms. Inter-
estingly,this list contains three proteins that are among the major
NADH/NAD+ consumersof thecell.Twoof them–alcoholdehy-
drogenase Adh1 and the predominant yeast GAPDH Tdh3 – are
found in physical complex with Sir2 (Gavin et al., 2002). In both
cases, low-scale genetic interaction studies conﬁrmed that they
inﬂuence the biological activity of Sir2 (Figure 2) .T h eﬁ r s tp r o -
tein, the predominant yeast GAPDH Tdh3, is a central enzyme
of glycolysis and reduces NAD+ to NADH in its catabolic role,
but oxidizes NADH in its gluconeogenetic function (Tristan et al.,
2011). A genetic screen conducted in the lab of Scott Holmes
revealed that overexpression of Tdh3 rescues lethality caused by
GAL1-promoter driven overexpression of Sir2, indicating a mod-
ulation of Sir2 activity by yeast GAPDH (Matecic et al., 2002).
Later,our investigations revealed that overexpression of Tdh3 and
E. coli GAPDH increases the rate of mitotic recombination in a
Sir2 dependent manner (Ralser et al.,2009b). This phenotype was
dependent on the catalytic activity of Sir2, and, interestingly, a
www.frontiersin.org March 2012 | Volume 3 | Article 32 | 5Ralser et al. Sir2 and yeast metabolism
FIGURE 1 |A metabolism-centric interaction network for Sir2. (A)
Network of 84 direct interactors of Sir2; the 40 genes associated with the
GO term “metabolism” and/or “carbohydrate metabolism” are highlighted
in blue or purple, respectively. (SeeTableA1 in Appendix for GO terms
associated with these Sir2 interactors). (B)The network (A) expanded with
the direct interactors of the 40 genes with annotated metabolic function.
This network containing ﬁrst and second order metabolism related Sir2
interactors interconnects with 2888 vertices half of the yeast proteome. We
apologize that due to this complexity, not all genes names may be readable.
(A,B) Physical- and genetic-interactors for Sir2 were obtained from the
BioGrid database as of December 2011 and illustrated with OSPrey (Stark
et al., 2006).
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function of metabolic activity: The recombination frequency in
yeast overexpressing Tdh3 increased from 3 times over wild-type
tomorethan10timesinexponentialbatchcultures,thecondition
that exhibits the highest glycolytic ﬂux (Ralser et al., 2009b).
Similar observations were made with alcohol dehydrogenase
ADH1, another component of the Sir2 protein complex (Gavin
et al.,2002;Figure2B).Adh1 catalyzes the conversion of acetalde-
hyde to ethanol,regenerating NAD+. Overexpression of theAdh1
enzyme increased both the NAD+/NADH ratio and the activity
of Sir2. Moreover, this treatment caused a 30% extension in yeast
replicative life span (Reverter-Branchat et al., 2007). Thus, it is
conceivable that in the close proximity within a protein complex,
metabolic enzymes GAPDH (Tdh3) and alcohol dehydrogenase
(Adh1) provide or deprive NAD+ that is used by Sir2. As the cat-
alytic reactions catalyzed by Tdh3 and Adh1 are reversible, this
catabolicfunctiondoesnotonlyrelyontheoverallmetabolicﬂux,
but also on the reaction equilibrium in the microenvironment:
these enzyme may provide or metabolize NAD+ dependent on
their localization.
The situation of the third metabolic enzyme, malate dehy-
drogenase Mdh1 is different, as it localizes to mitochondria,
were, to our knowledge, yeast Sir2 is not localized (Blander
and Guarente, 2004) Mdh1p, is involved in the citrate cycle
and component of the malate-aspartate NADH shuttle. How-
ever, it has been reported that Mdh1 is over-expressed under
conditions of calorie restriction (Lee and Lee, 2008), and that
ectopic overexpression of Mdh1 causes extension of replicative
lifespan. Remarkably, this lifespan extension was Sir2 depen-
dent (Easlon et al., 2008). Although these proteins do not co-
localize, they are part of a heavily interconnected interaction
sub-network involving proteins Sir2, Mdh1, Rad53, Aat1, Fob1,
and Hst1 (Figure 2C). Thus, although physical association of the
two proteins may be unlikely as they predominantly localize to
different compartments, they are involved in a network of close
geneticinteractions,andtheirinterplayisinvolvedinyeastreplica-
tive lifespan. Nonetheless, it remains possible that either Sir2 or
Mdh1 do co-localize under conditions which have not yet been
deﬁned.
FIGURE2|N A D
+ feeding or depletion in the Sir2 microenvironment.
(A)The NAD(H) metabolizing glycolytic enzyme GAPDH (Tdh3) is found in
the same protein complex as Sir2. At high glycolytic ﬂux, GAPDH deprives
NAD
+ in close proximity to Sir2; during gluconeogenesis it generates
NAD
+. Genetic interplay ofTdh3 and Sir2 inﬂuences the rate of mitotic
recombination. (B)The predominant cytoplasmic alcohol dehydrogenase
(Adh11) also complexes with Sir2. Adh1 overexpression increased the
NAD
+/NADH ratio and Sir2 activity as well as prolonged yeast replicative
lifespan. (C) Mitochondrial malate dehydrogenase Mdh1 is up-regulated
during caloric restriction. Its overexpression increases NADH oxidation and
prolongs replicative lifespan in a Sir2 dependent manner. Complex
formation between Sir2 and Mdh1 has not been reported, but both
proteins are interconnected through a dense genetic interaction network
involving Rad53, Aat1, Fob1, and Hst1 (blue circle).
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MetabolicregulationbySir2hasbeenassociatedwithNAD(H)
biosynthesis and salvage pathways. These differ in some, but
important, enzymatic steps among the eukaryotic lineage. While
mammalsprevalentlyusenicotinamideasthemainNAD+ source,
single-cellular eukaryotes like S. cerevisiae have focused on uti-
lizing tryptophan and nicotinic acid as precursors for NAD(H)
biosynthesis (Rongvaux et al., 2003). Due to the lack of a
homolog to the mammalian Nicotinamide phosphoribosyltrans-
ferase (NAMPT) enzyme, the budding yeast is unable to synthe-
size NAD(H) directly from the precursor nicotinamide. Hence,
nicotinamide gets converted to nicotinic acid, a substrate used by
Npt1(nicotinicacidphosphoribosyltransferase),toproducenico-
tinic acid mononucleotide (NaMN). This metabolite is further
c o n v e r t e dt oN A D + by two additional enzymatic steps involv-
ing Nma1/Nma2 that generate deamido-NAD, and Qns1, which
generates NAD+ from deamido-NAD (Rongvaux et al., 2003).
Although S. cerevisiae does not possess NAMPT or nicotinamide
mononucleotide (NMN), it was shown that components of the
NAD+ biosynthesisandsalvagepathwaysinteractwithSir2(Gallo
et al.,2004).
Interestingly, also the quite recently discovered nicotinamide
riboside salvage pathway is involved in the regulation of Sir2, and
affects replicative lifespan. The eukaryotic nicotinamide riboside
kinase (Nrk) converts nicotinamide riboside to NAD+ by phos-
phorylation and adenylylation (Tempel et al.,2007). This pathway
promoted Sir2 dependent repression of recombination,improved
gene silencing, and extended lifespan without calorie restriction,
but was dependent on the rate of NAD+ synthesis (Belenky et al.,
2007).
In general, this close association with central metabolic path-
ways seem to be speciﬁc for Sir2. In Figure 3, we illustrate the
interaction network of SIR2 and its homologous genes HST1-4.
Although they are closely interconnected, the common interac-
tors with a GO annotation metabolism have been associated with
assembly or disassembly of the chromatin and, rather then with
energy or intermediate-yielding metabolic pathways.
Sir2 CATALYZED CLEAVAGE OF NAD+ AS REGULATORY
METABOLIC REACTION
Another interesting,but still in its entire magnitude elusive mech-
anism in metabolic regulation concerns the putative signaling
functionof thecleavageproductsof NAD+ (LuandLin,2010;Qiu
et al., 2010b). These are formed when Sir2 is active as a protein
deacetylase.Atlowefﬁciency,theADPribosemoietycanbetrans-
ferred to the protein substrates like histone H4, but the majority
yields nicotinamide and a unique metabolite, 2 O-acetyl-ADP-
ribose (OAADPR; Imai et al., 2000; Tanner et al., 2000; Moazed,
2001;TannyandMoazed,2001;Bittermanetal.,2002;Jacksonand
Denu, 2002). There is experimental evidence that OAADPR rep-
resents a reporter metabolite with signaling function (Borra et al.,
FIGURE 3 |An interaction network for SIR2 and HST1-4 indicates
metabolism-speciﬁcity for SIR2. Genetic and physical interaction data for
SIR2 and HST1, HST2, HST3, and HST4 was obtained from yeast BioGrid
database (01/2012; Stark et al., 2006). Genes associated with GO terms
metabolism are highlighted in blue, those for carbon metabolism in pink.
Sir2 has the highest number of metabolism related interactors. Moreover,
metabolism related HST1-4 interactors predominantly contain proteins
involved in assembly, disassembly and repair of chromatin and DNA, rather
then enzymes of primary and intermediary metabolism. (SeeTableA1 in
Appendix for GO terms associated with Sir2 interactors).
Frontiers in Pharmacology | Experimental Pharmacology and Drug Discovery March 2012 | Volume 3 | Article 32 | 8Ralser et al. Sir2 and yeast metabolism
2002). In yeast, where NAD+ is concentrated is the millimolar
range, OAADPR levels of 0.5μMh a v eb e e nd e t e c t e d( Lee et al.,
2008). Furthermore, Lee et al. (2008) provided strong evidence
thatSIR2 and its paralogous genes are the only source of this mol-
ecule in yeast, and that the Nudix hydrolaseYsa1 is involved in its
degradation in vivo.
OAADPR has biological activity, although its exact molecu-
lar function remains elusive. Microinjection of OAADPR blocked
oocyte maturation and cell division in Asterina miniata (Borra
et al., 2002). Additional in vitro studies demonstrated that
OAADPR binds to the cation channel TRPM2 (Grubisha et al.,
2006) and the histone variant histone macroH2A1.1 (Kustatscher
et al., 2005; Tong and Denu, 2010). Moreover, OAADPR pro-
motes the association of multiple copies of Sir3 with Sir2/Sir4
and induces a structural rearrangement in the SIR complex (Liou
et al.,2005). These studies suggest OAADPR functions as a signal-
ing molecule and second messenger; however, there is a paucity
of information that directly links cellular OAADPR with sirtuin
functions.
More details are known about the second molecule, nicoti-
namide, which is a precursor of nicotinic acid (niacin/vitamin
B3). Nicotinamide acts as inhibitor of Sir2. First, it had been
reported that yeast silencing, rDNA recombination, and replica-
tive lifespan in sir2Δ yeast depend on nicotinamide concentra-
tion (Bitterman et al., 2002). Then, it was demonstrated that the
endogenous level of nicotinamide limits Sir2 activity in wild-type
yeast cells,and that this property can be antagonized by isonicoti-
namide, which caused an increase in Sir2 deacetylation activity
(Sauve et al.,2005). This property may be explained by a Sir2 cat-
alyzed transglycosidation reaction, were nicotinamide intercepts
an ADP-ribosyl-enzyme-acetyl peptide intermediate regenerating
NAD+ (Jackson et al., 2003). Thus, high deacetylase activity in
theSir2microenvironmentislikelypreventedbyefﬁcientproduct
inhibition of Sir2.
Takentogether,theSir2’scatalyticactivityinterferesinmultiple
wayswithcellularmetabolism,andtheotherwayaround,changes
in metabolism modulate Sir2 activity. The action of Sir2 through
its deacetylase activity is better understood, but also the indirect
actionof Sir2throughitscatabolicproductsOAADPRandnicoti-
namide seems of high biological relevance. The analysis of the
latter under in vivo conditions is very challenging, as it induces
a very complex biological response, which demands for further
intensive research both at the molecular/biochemical as well as at
the systems biology level.
SUMMARY AND CONCLUSION
Stability and dynamics of metabolic networks require the interac-
tion of the small molecule world with the genome and proteome.
Sirtuins,at the forefront its founding member Sir2,belong to pro-
teins which fulﬁll this function in a broad context. They interact
withmetabolites,proteinsandnucleicacids,andspreadmetabolic
signals through these molecular universes. However the complex-
ity of these networks and their interconnectivity makes it difﬁcult
to associate unique molecular mechanisms with complex phe-
notypes such as an extended lifespan. Therefore, there remain
severalquestionstobeansweredhowSir2inyeastandthesirtuins
in mammals regulate metabolism and thereby increase lifespan
and cardiovascular health. Mechanistically, the function of Sir2
in increasing yeast replicative (but not chronological) lifespan is
largely overlapping with caloric restriction, and is related to the
activity and the stability of the metabolic network. Moreover,Sir2
is present in protein complexes containing major NAD+ produc-
ing enzymes in the cell, indicating that this enzyme is supplied
or deprived from NAD+ in its microenvironment, dependent
on the metabolic activity and ﬂux. While these considerations
are intuitively convincing, what is still needed and in most cases
still missing, is a detailed chain of events based on biochemistry,
which would explain the function of Sir2 and sirtuins in meta-
bolic regulation and consequently in regulation of redox state,the
aging process,and the diseases of aging like cancer,cardiovascular
disease, and neurodegenerative disease.
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APPENDIX
TableA1 | Data analyzed by GO slim mapper, http://www.yeastgenome.org/, 02/02/2012.
GOID GO term Frequency Genome frequency Gene(s)
RESULTS FORTHE MAPPING OF 39 GENESTOTHEYEAST GO-SLIM FUNCTION
3677 DNA binding 5 out of 39 genes, 12.8% 369 of 6311 genes, 5.8% MCM2, CDC6, RAD52, ORC5, RAD53
42393 Histone binding 4 out of 39 genes, 10.3% 39 of 6311 genes, 0.6% DOT1, GCN5,YNG2, RSC4
16491 Oxidoreductase activity 4 out of 39 genes, 10.3% 276 of 6311 genes, 4.4% SUR2,TDH3, MDH1, ADH1
16746 Transferase activity, transferring
acyl groups
4 out of 39 genes, 10.3% 116 of 6311 genes, 1.8% EPL1, GCN5,YNG2, ESA1
3723 RNA binding 4 out of 39 genes, 10.3% 753 of 6311 genes, 11.9% SET1, MDH1,YEF3, NRD1
16887 ATPase activity 4 out of 39 genes, 10.3% 230 of 6311 genes, 3.6% CDC6, RSC4,YEF3, HSP82
16874 Ligase activity 3 out of 39 genes, 7 .7% 181 of 6311 genes, 2.9% SLX5, RAD6, ACS2
3674 Molecular function unknown 3 out of 39 genes, 7 .7% 1990 of 6311 genes, 31.5% ESC2, RRP4, MUC1
8168 Methyltransferase activity 2 out of 39 genes, 5.1% 90 of 6311 genes, 1.4% DOT1, SET1
16829 Lyase activity 2 out of 39 genes, 5.1% 84 of 6311 genes, 1.3% PCK1, PAP2
16301 Kinase activity 2 out of 39 genes, 5.1% 199 of 6311 genes, 3.2% HXK2, RAD53
988 Protein binding transcription
factor activity
2 out of 39 genes, 5.1% 127 of 6311 genes, 2.0% GCN5, RPD3
8289 Lipid binding 1 out of 39 genes, 2.6% 92 of 6311 genes, 1.5% SCS2
16810 Hydrolase activity, acting on
carbon–nitrogen (but not
peptide) bonds
1 out of 39 genes, 2.6% 61 of 6311 genes, 1% RPD3
8135 Translation factor activity, nucleic
acid binding
1 out of 39 genes, 2.6% 44 of 6311 genes, 0.7% YEF3
3729 mRNA binding 1 out of 39 genes, 2.6% 68 of 6311 genes, 1.1% MDH1
16757 Transferase activity, transferring
glycosyl groups
1 out of 39 genes, 2.6% 100 of 6311 genes, 1.6% NPT1
16779 Nucleotidyltransferase activity 1 out of 39 genes, 2.6% 113 of 6311 genes, 1.8% PAP2
5198 Structural molecule activity 1 out of 39 genes, 2.6% 356 of 6311 genes, 5.6% HPR1
16798 Hydrolase activity, acting on
glycosyl bonds
1 out of 39 genes, 2.6% 47 of 6311 genes, 0.7% BGL2
8233 Peptidase activity 1 out of 39 genes, 2.6% 137 of 6311 genes, 2.2% ULP2
51082 Unfolded protein binding 1 out of 39 genes, 2.6% 66 of 6311 genes, 1.0% HSP82
4386 Helicase activity 1 out of 39 genes, 2.6% 80 of 6311 genes, 1.3% CHL1
3924 GTPase activity 1 out of 39 genes, 2.6% 58 of 6311 genes, 0.9% CDC6
30234 Enzyme regulator activity 1 out of 39 genes, 2.6% 219 of 6311 genes, 3.5% KAP95
8565 Protein transporter activity 1 out of 39 genes, 2.6% 52 of 6311 genes, 0.8% KAP95
32182 Small conjugating protein binding 1 out of 39 genes, 2.6% 43 of 6311 genes, 0.7% SLX5
Other Other 3 out of 39 genes, 7 .7% MCD1, AAT1, UBI4
RESULTS FORTHE MAPPING OF 39 GENESTOTHEYEAST GO-SLIM PROCESS
6974 Response to DNA damage
stimulus
13 out of 39 genes, 33.3% 281 of 6311 genes, 4.5% MCM2, MCD1, SLX5, HPR1, ESC2, DOT1,
EPL1, RAD6, YNG2, RAD52, PAP2, ESA1,
RAD53
6281 DNA repair 12 out of 39 genes, 30.8% 232 of 6311 genes, 3.7% MCM2, MCD1, HPR1, ESC2, DOT1, EPL1,
RAD6,YNG2, RAD52, PAP2, ESA1, RAD53
6325 Chromatin organization 10 out of 39 genes, 25.6% 223 of 6311 genes, 3.5% DOT1, EPL1, RAD6, GCN5, YNG2, SET1,
RSC4, ACS2, RPD3, ESA1
6366 Transcription from RNA
polymerase II promoter
9 out of 39 genes, 23.1% 438 of 6311 genes, 6.9% HPR1, EPL1, RAD6, GCN5, SET1, RSC4,
NRD1, RPD3, ESA1
(Continued)
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TableA1 | Continued
GOID GO term Frequency Genome frequency Gene(s)
278 Mitotic cell cycle 9 out of 39 genes, 23.1% 288 of 6311 genes, 4.6% MCM2, MCD1, ESC2, RAD6, ULP2, CDC6,
RSC4, RPD3, CHL1
16570 Histone modiﬁcation 9 out of 39 genes, 23.1% 98 of 6311 genes, 1.6% DOT1, EPL1, RAD6, GCN5, YNG2, SET1,
ACS2, RPD3, ESA1
6310 DNA recombination 8 out of 39 genes, 20.5% 149 of 6311 genes, 2.4% MCM2, HPR1, ESC2, DOT1, RAD6, RAD52,
RPD3, CHL1
51726 Regulation of cell cycle 7 out of 39 genes, 17 .9% 183 of 6311 genes, 2.9% ESC2, DOT1, RAD6, ULP2, RPD3, ESA1,
RAD53
6260 DNA replication 7 out of 39 genes, 17 .9% 140 of 6311 genes, 2.2% MCM2, CDC6, ORC5, RPD3, CHL1, RAD53,
HSP82
43543 Protein acylation 6 out of 39 genes, 15.4% 64 of 6311 genes, 1.0% EPL1, GCN5,YNG2, SET1, ACS2, ESA1
18193 Peptidyl-amino acid modiﬁcation 6 out of 39 genes, 15.4% 83 of 6311 genes, 1.3% EPL1, GCN5,YNG2, SET1, ACS2, ESA1
6354 Transcription elongation,
DNA-dependent
5 out of 39 genes, 12.8% 72 of 6311 genes, 1.1% HPR1, GCN5, RSC4, RPD3, ESA1
70647 Protein modiﬁcation by small
protein conjugation or removal
5 out of 39 genes, 12.8% 149 of 6311 genes, 2.4% SLX5, RAD6, ULP2, UBI4, KAP95
5975 Carbohydrate metabolic process 4 out of 39 genes, 10.3% 275 of 6311 genes, 4.4% HXK2,TDH3, PCK1, ADH1
6091 Generation of precursor
metabolites and energy
4 out of 39 genes, 10.3% 163 of 6311 genes, 2.6% HXK2,TDH3, MDH1, ADH1
51052 Regulation of DNA metabolic
process
4 out of 39 genes, 10.3% 71 of 6311 genes, 1.1% CDC6, RPD3, CHL1, HSP82
51186 Cofactor metabolic process 4 out of 39 genes, 10.3% 164 of 6311 genes, 2.6% MDH1, ACS2, ADH1, NPT1
48285 Organelle ﬁssion 4 out of 39 genes, 10.3% 124 of 6311 genes, 2% MCD1, ESC2, ULP2, CHL1
51321 Meiotic cell cycle 4 out of 39 genes, 10.3% 162 of 6311 genes, 2.6% DOT1, RAD6, RAD52, RPD3
32200 Telomere organization 4 out of 39 genes, 10.3% 67 of 6311 genes, 1.1% SLX5, SET1, RAD52, HSP82
7059 Chromosome segregation 3 out of 39 genes, 7 .7% 131 of 6311 genes, 2.1% MCD1, ESC2, CHL1
33043 Regulation of organelle
organization
3 out of 39 genes, 7 .7% 143 of 6311 genes, 2.3% SET1, ULP2, HSP82
6605 Protein targeting 3 out of 39 genes, 7 .7% 266 of 6311 genes, 4.2% SCS2, KAP95, HSP82
6629 Lipid metabolic process 3 out of 39 genes, 7 .7% 262 of 6311 genes, 4.2% SUR2, SCS2, KAP95
55086 Nucleobase-containing small
molecule metabolic process
3 out of 39 genes, 7 .7% 183 of 6311 genes, 2.9% ADH1, NPT1, RAD53
51169 Nuclear transport 3 out of 39 genes, 7 .7% 163 of 6311 genes, 2.6% HPR1, SCS2, KAP95
8213 Protein alkylation 2 out of 39 genes, 5.1% 41 of 6311 genes, 0.6% DOT1, SET1
43934 Sporulation 2 out of 39 genes, 5.1% 126 of 6311 genes, 2% SET1, UBI4
31399 Regulation of protein
modiﬁcation process
2 out of 39 genes, 5.1% 73 of 6311 genes, 1.2% SET1, KAP95
51049 Regulation of transport 2 out of 39 genes, 5.1% 58 of 6311 genes, 0.9% SCS2, RAD6
6520 Cellular amino acid metabolic
process
2 out of 39 genes, 5.1% 240 of 6311 genes, 3.8% AAT1, ADH1
6401 RNA catabolic process 2 out of 39 genes, 5.1% 106 of 6311 genes, 1.7% RRP4, PAP2
70271 Protein complex biogenesis 2 out of 39 genes, 5.1% 222 of 6311 genes, 3.5% KAP95, HSP82
43144 snoRNA processing 2 out of 39 genes, 5.1% 37 of 6311 genes, 0.6% RRP4, PAP2
71554 Cell wall organization or
biogenesis
1 out of 39 genes, 2.6% 211 of 6311 genes, 3.3% BGL2
6397 mRNA processing 1 out of 39 genes, 2.6% 185 of 6311 genes, 2.9% HPR1
6360 Transcription from RNA
polymerase I promoter
1 out of 39 genes, 2.6% 63 of 6311 genes, 1% RPD3
45333 Cellular respiration 1 out of 39 genes, 2.6% 90 of 6311 genes, 1.4% MDH1
6457 Protein folding 1 out of 39 genes, 2.6% 88 of 6311 genes, 1.4% HSP82
42221 Response to chemical stimulus 1 out of 39 genes, 2.6% 351 of 6311 genes, 5.6% HXK2
6414 Translational elongation 1 out of 39 genes, 2.6% 332 of 6311 genes, 5.3% YEF3
(Continued)
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TableA1 | Continued
GOID GO term Frequency Genome frequency Gene(s)
7005 Mitochondrion organization 1 out of 39 genes, 2.6% 333 of 6311 genes, 5.3% HSP82
6353 Transcription termination,
DNA-dependent
1 out of 39 genes, 2.6% 34 of 6311 genes, 0.5% NRD1
15931 Nucleobase-containing
compound transport
1 out of 39 genes, 2.6% 116 of 6311 genes, 1.8% HPR1
6869 Lipid transport 1 out of 39 genes, 2.6% 49 of 6311 genes, 0.8% SCS2
55085 Transmembrane transport 1 out of 39 genes, 2.6% 186 of 6311 genes, 2.9% SCS2
51603 Proteolysis involved in cellular
protein catabolic process
1 out of 39 genes, 2.6% 192 of 6311 genes, 3.0% RAD6
6997 Nucleus organization 1 out of 39 genes, 2.6% 54 of 6311 genes, 0.9% KAP95
7124 Pseudohyphal growth 1 out of 39 genes, 2.6% 65 of 6311 genes, 1.0% MUC1
8643 Carbohydrate transport 1 out of 39 genes, 2.6% 38 of 6311 genes, 0.6% HXK2
6364 rRNA processing 1 out of 39 genes, 2.6% 294 of 6311 genes, 4.7% RRP4
1403 Invasive growth in response to
glucose limitation
1 out of 39 genes, 2.6% 52 of 6311 genes, 0.8% MUC1
9408 Response to heat 1 out of 39 genes, 2.6% 47 of 6311 genes, 0.7% RPD3
48308 Organelle inheritance 1 out of 39 genes, 2.6% 51 of 6311 genes, 0.8% SCS2
6970 Response to osmotic stress 1 out of 39 genes, 2.6% 75 of 6311 genes, 1.2% HSP82
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